Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Clinical trial NCT05991973 · COMPLETED

Trial details

NCT number: NCT05991973
Sponsor: Zhejiang University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

T Lymphoblastic Leukemia/Lymphoma

Start date: 2023-07-15
Primary completion: 2025-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.